(NP (NP Selective/JJ effects/NNS) (PP of/IN (NP DNA/NN damaging/NN agents/NNS)) (PP on/IN (NP (NP HIV/NN long/JJ terminal/JJ repeat/NN activation/NN) and/CC (NP (NP virus/NN replication/NN) (ADVP in/FW vitro/FW)))) ./.)
(S (NP-SBJ Much/JJ attention/NN) (VP has/VBZ (ADVP-TMP recently/RB) (VP focused/VBN (PP on/IN (NP the/DT observation/NN (SBAR that/IN (S (NP-SBJ UV/NN light/NN) (VP can/MD (VP activate/VB (NP (NP (NP the/DT long/JJ terminal/JJ repeat/NN) (PRN -LRB-/-LRB- (NP LTR/NN) -RRB-/-RRB-)) (PP of/IN (NP (NP the/DT human/JJ immunodeficiency/NN virus/NN) (PRN -LRB-/-LRB- (NP HIV/NN) -RRB-/-RRB-)))))))))))) ./.)
(S (SBAR Although/IN (S (NP-SBJ (NP the/DT mechanism/NN) (PP of/IN (NP LTR/NN activation/NN))) (VP remains/VBZ (ADJP-PRD obscure/JJ)))) ,/, (NP-SBJ (NP several/JJ lines/NNS) (PP of/IN (NP investigation/NN))) (VP have/VBP (VP suggested/VBN (SBAR that/IN (S (NP-SBJ it/PRP) (VP is/VBZ (NP-PRD (NP a/DT result/NN) (PP of/IN (NP (NP activation/NN) (PP of/IN (NP the/DT NF-kappa/NN B/NN transcription/NN factor/NN -LRB-/-LRB- s/NNS -RRB-/-RRB-)) (PP-TMP following/VBG (NP (NP signaling/NN events/NNS) (ADJP related/JJ (PP to/TO (NP generalized/VBN DNA/NN damage/NN))))))))))))) ./.)
(S (PP In/IN (NP this/DT report/NN)) ,/, (NP-SBJ we/PRP) (VP present/VBP (NP (NP data/NNS) (VP demonstrating/NN (SBAR-COOD (SBAR that/IN (S (NP-SBJ HIV/NN LTR/NN activation/NN) (VP is/VBZ (NP-PRD-COOD not/RB (NP (NP a/DT general/JJ consequence/NN) (PP of/IN (NP cellular/JJ DNA/NN damage/NN))) ,/, (CONJP but/CC rather/RB) (NP (NP a/DT process/NN) (ADJP unique/JJ (PP to/TO (NP specific/JJ genotoxic/JJ stimuli/NNS)))))))) ,/, and/CC (SBAR that/IN (S (NP-SBJ it/PRP) (VP does/VBZ (ADVP not/RB necessarily/RB) (VP depend/VB (PP on/IN (NP (NP activation/NN) (PP of/IN (NP NF-kappa/NN B/NN)))))))))))) ./.)
(S (ADVP Furthermore/RB) ,/, (NP-SBJ we/PRP) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ (NP several/JJ) (PP of/IN (NP these/DT agents/NNS))) (VP can/MD (ADVP significantly/RB) (VP (VP-COOD (VP increase/VB (NP HIV/NN replication/NN)) and/CC (VP accelerate/VB (NP CD4-positive/JJ lymphocyte/NN cytotoxicity/NN))) (ADVP in/FW vitro/FW)))))) ./.)
(S (NP-SBJ These/DT findings/NNS) ,/, (ADVP therefore/RB) ,/, (VP could/MD (VP have/VB (NP clinical/JJ significance/NN) (PP to/TO (NP (NP AIDS/NN patients/NNS) (PP with/IN (NP malignancies/NNS)) (SBAR (WHNP-81 who/WP) (S (NP-SBJ *T*-81/-NONE-) (VP are/VBP (VP undergoing/VBG (NP-COOD (NP radiotherapy/NN) and/CC (NP chemotherapy/NN)))))))))) ./.)
